Emerging technologies in ART are pushing the boundaries of reproductive medicine, offering hope to individuals facing infertility while raising profound ethical and societal questions. From AI-driven embryo selection to in vitro gametogenesis and gene editing, these advancements promise to redefine parenthood. However, translating these innovations into clinical practice requires careful consideration of safety, accessibility, and ethical implications to ensure equitable and responsible use. Once an ART innovation proves successful in animal models, it progresses to clinical trials in humans, beginning with small, carefully monitored studies. Innovations like time-lapse imaging, laser-assisted hatching, and AI-driven embryo selection have all transitioned from theory or animal-based research to human use after rigorous validation.